ArticleBMC infectious diseases2025
Willingness to accept Doxycycline post-exposure prophylaxis for bacterial stis prevention among men who have sex with men in Southern China: a cross-sectional analysis.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Appropriate use of Doxy-PEP and inappropriate antibiotic self-medication for STI management: insights from a LGBTQIA+ survey in Italy.BMC public health · 2026Article
- Doxycycline prophylaxis for sexually transmitted infections prevention among men who have sex with men in China.Frontiers in public health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundDoxycycline post-exposure prophylaxis (doxy-PEP) has the potential to decrease the incidence of sexually transmitted infections (STIs) among men who have sex with men (MSM). However, there is a limited literature on willingness to use doxy-PEP among Chinese MSM. This study aimed to examine the willingness to use doxy-PEP and its associated factors among MSM in China.
methodsIn 2023, we conducted a cross-sectional study in four cities in Guangdong provinces in South China. Data were collected on social-demographic characteristics, sexual behaviors, and the willingness to use doxy-PEP. Multivariable logistic regression analysis was employed to identify factors associated with the willingness to use doxy-PEP.
resultsA total of 884 individuals were included in this study. Of these, 53.5% reported a willingness to use doxy-PEP for the prevention of STIs. The main concerns for those unwilling to use doxy-PEP were related to its efficacy (82.5%) and safety (81.7%). Multivariable logistic regression indicated that participants were more likely to express willingness to use doxy-PEP if they had female sexual partners in the past 6 months (adjusted Odds Ratio (aOR): 1.58, 95% CI: 1.11-2.25), had prior or current doxy-PEP use (aOR = 2.39, 95% CI: 1.13-5.05), or had peers currently using doxy-PEP (aOR = 1.58, 95% CI: 1.09-2.30).
conclusionsThe willingness to use doxy-PEP among MSM in South China is relatively low. These findings highlight the need for effective educational and targeted intervention strategies to raise awareness and knowledge toward using doxy-PEP among MSM in China.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.